FDA Inspection 1308780 — Coupler LLC

Coupler LLC — FEI 3003734940

The FDA completed an inspection of Coupler LLC on Mar 2, 2026 in West Chester, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 2, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
West Chester, PA (United States)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
136121 CFR 211.100(a)Absence of Written Procedures
186821 CFR 211.94(b)Protection from external factors
362921 CFR 211.170(b)Reserve samples identified, representative, stored

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.